课题基金 / 基金详情

Cell cycle transactivation factor E2F-4 is associate with the ganstrointestinal carcinogenesis and/or acquisition of chemoresistance

Cell cycle transactivation factor E2F-4 is associate with the ganstrointestinal carcinogenesis and/or acquisition of chemoresistance
细胞周期反式激活因子E2F-4与胃肠癌发生和/或化疗耐药性的获得有关
批准号:
11671237
负责人:
TANAKA Noriaki
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

TANAKA Noriaki的其他基金

相似基金

相关文献

中文摘要
翻译
E2 F是一个转录因子家族,参与调控G1-S转换所需的基因表达。我们以前在散发性结直肠癌的一个亚组中检测到E2 F-4基因三核苷酸重复编码序列的肿瘤特异性突变。本研究的目的是调查这些E2 F-4突变的潜在功能后果。我们用含有野生型以及突变型E2 F-4 cDNA的表达构建体转染NIH 3 T3成纤维细胞,并检查E2 F-4突变对增殖的影响。通过将E2 F-4与DP-2构建体瞬时共转染到培养的人细胞中,也检查了E2 F共有启动子序列反式激活的改变。过表达突变体E2 F-4的转染细胞克隆生长更迅速,增殖细胞核抗原(PCNA)的免疫组化染色增加,表现出更高的增殖活性。E2 F-4的所有三种突变形式均显示E2 F共有启动子序列的反式激活升高。因此,突变体E2 F-4s的表达赋予体内生长优势,并且这种效应可能与获得肿瘤表型有关。
英文摘要
E2F is a family of transcription factors implicated in the regulation of gene expression required for progression through the G1-S transition. We have previously detected tumor-specific mutations at a trinucleotide repeat coding sequence of E2F-4 gene in a subset of human sporadic colorectal cancers. The purpose of this study was to investigate the potential functional consequences of these E2F-4 mutations. We transfected NIH3T3 fibroblasts with expression constructs containing wild type as well as mutant E2F-4 cDNA and the effect of the E2F-4 mutations on proliferation was examined. Alteration in transactivation of the E2F consensus promoter sequence was also examined by transient cotransfection of a E2F-4 with a DP-2 construct into cultured human cells. Transfected cell clones overexpressing mutant E2F-4 grew more rapidly and showed higher proliferative activity by increased immunohistochemical staining for proliferating cell nuclear antigen (PCNA). All three mutant forms of E2F-4 showed elevated transactivation of the E2F consensus promoter sequence. Thus, expression of mutant E2F-4s confers a growth advantage in vivo, and this effect may be related to the acquisition of a neoplastic phenotype.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsubara N, et al.: "Multiple tumors and a novel E2F-4 mutation"Digestion. 62. 213-216 (2000)
Matsubara N 等人:“多种肿瘤和新型 E2F-4 突变”消化。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
馬場正三他: "21世紀の大腸癌診断治療戦略のために HNPCC in the year2000"株式会社マイライフ社. 71 (2000)
Shozo Baba等:“2000年21世纪HNPCC的结直肠癌诊断和治疗策略” My Life Co., Ltd. 71 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsubara N, et al: "The farthest 3' distal end APC mutation identified in attenuated adenomatous polyposis coli with extracolonic manifestations."Dis.Colon Rectum. 43・5. 720-721 (2000)
Matsubara N 等人:“在具有结肠外表现的减毒腺瘤性息肉病中鉴定出最远的 3 远端 APC 突变。”Dis.Colon Rectum。 720-721 (2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 14 条
    総合ビタミン製剤の連続投与が高度腎機能障害患者に及ぼす影響の解明
    • 批准号:
      19H00350
    • 项目类别:
      Grant-in-Aid for Encouragement of Scientists
    • 资助金额:
      $0.35万
    • 财政年份:
      2019
    • 负责人:
      TANAKA Noriaki
    • 依托单位:
    Contribution of chemokines and growth factors for the cervical lymph node metastasis in oral squamous cell carcinoma
    • 批准号:
      24792206
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.75万
    • 财政年份:
      2012
    • 负责人:
      TANAKA Noriaki
    • 依托单位:
    The relationship of MMPs and growth factors in the invasion mechanism of adenoid cystic carcinoma
    • 批准号:
      20791561
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.66万
    • 财政年份:
      2008
    • 负责人:
      TANAKA Noriaki
    • 依托单位:
    Hepatic differentiation of human embryonic stem cells and its application to the development of a bioartificial liver system
    • 批准号:
      19390334
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2007
    • 负责人:
      TANAKA Noriaki
    • 依托单位:
    海外基金